Sujay Kango, EVP, Chief Commercial Officer at ACCELERON PHARMA INC (XLRN), sold 21,357 shares at $126.15 ($2.7M) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $2.7M XLRN by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.90 | 1,947 | $241K | 9.0% |
| 2 | $123.90 | 1,947 | $241K | 9.0% |
| 3 | $124.31 | 1,357 | $169K | 6.3% |
| 4 | $125.17 | 3,429 | $429K | 16.0% |
| 5 | $125.17 | 3,429 | $429K | 16.0% |
| 6 | $126.15 | 4,624 |
| $583K |
| 21.8% |
| 7 | $126.15 | 4,624 | $583K | 21.8% |
| Total | $125.31 avg | 21,357 | $2.7M | 100% |
| Filing → |
| XLRN | SELL | 2021-03-04 | $1.3M | — | Filing → |
| XLRN | SELL | 2020-02-14 | $112K | — | Filing → |
| XLRN | SELL | 2020-01-03 | $25K | — | Filing → |